Testing the mHealth app SyD to improve the physical and mental wellbeing of UK healthcare workers

Randomised controlled trial of the mHealth app SyD to improve the physical and mental wellbeing of UK healthcare workers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN41061413

Enrollment

500

Registered

2023-04-12

Start date

2021-06-01

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental health (anxiety, depression, stress), quality of life Mental and Behavioural Disorders

Interventions

The trial is designed carefully and deliberately to fully and prospectively elucidate all elements of comparison of the impact of SYD. Participants would be randomly assigned to one of the two trial

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. NHS staff with an NHS email address which can be used for this study 2. Age = 18 years 3. Own a personal smartphone device (iOS or Android-based) which can be used for this study 4. Sufficient English language ability to familiarise themselves with and engage with SYD and study assessments 5. Hospital Anxiety and Depression Scale (HADS) test score between 8 and 14 inclusive, indicating mild to moderate anxiety or depressive symptoms 6. Provision of informed consent

Exclusion criteria

Exclusion criteria: 1. Unwilling or unable to participate 2. Any other concurrent psychological interventions 3. Concurrent participation in an interventional clinical trial 4. People considered clinically extremely vulnerable from COVID-19: https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19)

Design outcomes

Primary

Measure	Time frame
1. WHO Quality of Life-BREF (WHOQOL-BREF) survey assessed global quality of life in the Control and Intervention group at Baseline, Month 1, 2, 3 & 6 2. EuroQoL EQ-5D-5L assessed Health-related quality of life in the Control and Intervention group at Baseline, Month 1, 2, 3 & 6	—

Secondary

Measure	Time frame
1. Perceived Stress Scale (PSS-4) was used for the Control and Intervention group at Baseline, Month 1, 2, 3 & 6 2. Hospital Anxiety and Depression Scale (HADS) was used for the Control and Intervention group at Baseline, Month 1, 2, 3 & 6	—

Countries

England, United Kingdom

Contacts

Public ContactSana Sajid

Sana.Sajid@southernhealth.nhs.uk-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026